Study: Dogs With Lymphoma, Melanoma and Mast Cell Tumors

Trial Summary

We are looking for client-owned dogs with lymphoma, melanoma or mast cell tumor to be enrolled in a study to evaluate a novel antibody-based therapy

Trial Funding

This study is fully funded for the duration of the study (140 days) including study drug and all study-related procedures

Trial Eligibility


  • Measurable skin tumor or metatstatic lymph node >=2 cm
  • No intraabdominal metastasis


  • At least measurable malignant tumor in the oral cavity, digit, skin or metastatic lymph node >=2cm
  • No pulmonary metastasis


  • All stages but must have at least one lymph node>= 2cm
  • No pulmonary or gastrointestinal involvement
  • Newly diagnosed or dogs that have completed no more than one chemotherapy protocol
Kansas Participation

For more information or to enroll your client and patient in this study, please contact Adrienne Scott or Dr. Heather Heeb at  (913) 642-9563.